参考文献/References:
[1]Humbert M,Kovacs G,Hoeper MM,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J,2022:ehac237.
[2]Young T,Peppard PE,Gottlieb DJ. Epidemiology of obstructive sleep apnea:a population health perspective[J]. Am J Respir Crit Care Med,2002,165(9):1217-1239.
[3]Benjafield AV,Ayas NT,Eastwood PR,et al. Estimation of the global prevalence and burden of obstructive sleep apnoea:a literature-based analysis[J]. Lancet Respir Med,2019,7(8):687-698.
[4] Javaheri S,Barbe F,Campos-Rodriguez F,et al. Sleep apnea:types,mechanisms,and clinical cardiovascular consequences[J]. J Am Coll Cardiol,2017,69(7):841-858.
[5]Yan L,Zhao Z,Zhao O,et al. The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea[J]. BMC Pulm Med,2021,21(1):378.
[6]David B Badesch,Gary E Raskob,C Greg Elliott,et al. Pulmonary arterial hypertension:baseline characteristics from the REVEAL Registry[J]. Chest,2010,137(2):376-387.
[7]Jilwan FN,Escourrou P,Garcia G,et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms[J]. Chest,2013,143(1):47-55.
[8]高柳,柳志红,赵智慧,等. 肺动脉高压合并阻塞性睡眠呼吸暂停患者的临床特点[J].中国循环杂志,2017,32(11): 1107-1111.
[9] Ball MK,Waypa GB,Mungai PT,et al. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α[J]. Am J Respir Crit Care Med,2014,189(3):314-324.
[10]Marrone O,Bellia V,Ferrara G,et al. Transmural pressure measurements. Importance in the assessment of pulmonary hypertension in obstructive sleep apneas[J]. Chest,1989,95(2):338-342.
[11]Sch?fer H,Hasper E,Ewig S,et al. Pulmonary haemodynamics in obstructive sleep apnoea:time course and associated factors[J]. Eur Respir J,1998,12(3):679-684.
[12]Adir Y,Humbert M,Chaouat A. Sleep-related breathing disorders and pulmonary hypertension[J]. Eur Respir J,2020,57(1):2002258.
[13]Marrone O,Bonsignore MR. Pulmonary haemodynamics in obstructive sleep apnoea[J]. Sleep Med Rev,2002,6(3):175-193.
[14]Ruocco G,Gavazzi A,Gonnelli S,et al. Pulmonary arterial hypertension and heart failure with preserved ejection fraction:are they so discordant?[J]. Cardiovasc Diagn Ther,2020,10(3):534-545.
[15]André S,Andreozzi F,van Overstraeten C,et al. Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity,nocturnal hypoxemia,and decreased sleep quality[J]. Respir Res,2020 21(1):35.
[16]Bouzerda A. Cardiovascular risk and obstructive sleep apnea[J]. Pan Afr Med J,2018,29:47.
[17]Shiomi T,Guilleminault C,Stoohs R,et al. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome[J]. Chest,1991,100(4):894-902.
[18]陈凤,冷玉芳,石亚静,等. 自主神经功能失调在阻塞型睡眠呼吸暂停综合征中的作用[J]. 国际麻醉学与复苏杂志,2021,42(6):642-646.
[19]Elmasry A,Lindberg E,Hedner J,et al. Obstructive sleep apnoea and urine catecholamines in hypertensive males:a population-based study[J]. Eur Respir J,2002,19(3):511-517.
[20]Ding X,Yu C,Liu Y,et al. Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling in a canine model[J]. Oncotarget,2016,7(36):57545-57555.
[21]Letsiou E,Bauer N. Endothelial extracellular vesicles in pulmonary function and disease[J]. Curr Top Membr,2018,82:197-256.
[22]Podszus T,Mayer J,Penzel T,et al. Nocturnal hemodynamics in patients with sleep apnea[J]. Eur J Respir Dis Suppl,1986,146:435-442.
[23]Winnicki M,Shamsuzzaman A,Lanfranchi P,et al. Erythropoietin and obstructive sleep apnea[J]. Am J Hypertens,2004,17(9):783-786.
[24]Lu F,Jiang T,Wang W,et al. Circulating fibrinogen levels are elevated in patients with obstructive sleep apnea:a systemic review and meta-analysis[J]. Sleep Med,2020,68:115-123.
[25]Davì G,Patrono C. Platelet activation and atherothrombosis[J]. N Engl J Med,2007,357(24):2482-94.
[26]Costa D,Benincasa G,Lucchese R,et al. Effect of nitric oxide reduction on arterial thrombosis[J]. Scand Cardiovasc J,2019,53(1):1-8.
[27]Gredic M,Blanco I,Kovacs G,et al.Pulmonary hypertension in chronic obstructive pulmonary disease[J]. Br J Pharmacol,2021,178(1):132-151.
[28]Masa JF,Mokhlesi B,Benítez I,et al. Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome. long-term Pickwick randomized controlled clinical trial[J]. Am J Respir Crit Care Med,2020,201(5):586-597.
[29]Mehra R,Chung MK,Olshansky B,et al. Sleep-disordered breathing and cardiac arrhythmias in adults:mechanistic insights and clinical implications:a scientific statement from the American Heart Association[J]. Circulation,2022,146(9):e119-e136.
[30] Tan JWC,Leow LC,Wong S,et al. Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease[J]. Eur Cardiol,2022,17:e16.
[31]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 成人阻塞性睡眠呼吸暂停基层诊疗指南（2018年）[J]. 中华全科医师杂志,2019,18(1):21-29.
[32]中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南（2011年修订版）[J]. 中华结核和呼吸杂志 ,2012,35(1):9-12.
[33]罗金梅,肖毅. 一种简便易行的筛查阻塞性睡眠呼吸暂停低通气综合征的问卷:STOP-Bang问卷[J].?中华结核和呼吸杂志,?2013,36(11):868-870.
[34] Hu M,Duan A,Huang Z,et al. Development and validation of a nomogram for predicting obstructive sleep apnea in patients with pulmonary arterial hypertension[J]. Nat Sci Sleep,2022,14:1375-1386.
[35] Sugiyama A,Shiota S,Yanagihara M,et al. The role of long‐term continuous positive airway pressure in the progression of obstructive sleep apnoea:a longitudinal cohort study[J]. J Sleep Res,2021(3):e13374.
[36]Masa JF,Pépin JL,Borel JC,et al. Obesity hypoventilation syndrome[J]. Eur Respir Rev,2019,28(151):180097.
[37]Sharma S,Stansbury R,Hackett B,et al. Sleep apnea and pulmonary hypertension:a riddle waiting to be solved[J]. Pharmacol Ther,2021,227:107935.
[38] Alchanatis M,Tourkohoriti G,Kakouros S,et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea:the effect of continuous positive airway pressure on pulmonary hemodynamics[J]. Respiration,2001,68(6):566-572.
[39]Arias MA,García-Río F,Alonso-Fernández A,et al. Pulmonary hypertension in obstructive sleep apnoea:effects of continuous positive airway pressure:a randomized,controlled cross-over study[J]. Eur Heart J,2006,27(9):1106-1113.
[40]Vitarelli A,Terzano C,Saponara M,et al. Assessment of right ventricular function in obstructive sleep apnea syndrome and effects of continuous positive airway pressure therapy:a pilot study[J]. Can J Cardiol 2015,31(7):823-831.
[41]Oliveira W,Poyares D,Cintra F,et al. Impact of continuous positive airway pressure treatment on right ventricle performance in patients with obstructive sleep apnoea,assessed by three-dimensional echocardiography[J]. Sleep Med,2012,13(5):510-516.
[42]Colish J,Walker JR,Elmayergi N,et al. Obstructive sleep apnea:effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers,echocardiography,and cardiac MRI[J]. Chest,2012,141(3):674-681.
[43] Chu AA,Yu HM,Yang H,et al. Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude[J].Sci Rep,2020,10(1):20186.
[44]王宇鑫,肖毅. 单纯阻塞性睡眠呼吸暂停能否导致肺动脉高压[J]. 中华结核和呼吸杂志,2021,44(10):914-921.
[45]Vachiéry JL,Tedford RJ,Rosenkranz S,et al. Pulmonary hypertension due to left heart disease[J]. Eur Respir J,2019,53(1):1801897.
[46]Antic NA,Catcheside P,Buchan C,et al. The effect of CPAP in normalizing daytime sleepiness,quality of life,and neurocognitive function in patients with moderate to severe OSA[J]. Sleep,2011,34(1):111-119.
相似文献/References:
[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(1):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(1):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(1):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[5]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(1):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[6]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(1):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[7]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(1):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[8]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(1):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[9]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(1):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[10]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(1):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]